STAT+: Trump can’t break free from vaccine politics

What’s Happening

So basically Trump is trying to shift the focus toward healthy eating and cheaper drugs.

But vaccines keeping coming back up. The Readout The Readout STAT Plus: CMS wants more drugmakers to join Medicaid most-favored nations pilot By Elaine Chen Business Business STAT Plus: CMS halts enrollment in Elevance’s Medicare Advantage plans, citing years of misconduct By Bob Herman Health Care Inc. (plot twist fr)

STAT Plus: Aetna’s ACA hospital prices, and a new Cigna deal By Bob Herman The Readout The Readout STAT Plus: A Merck cancer drug to watch By Meghana Keshavan The Readout The Readout STAT Plus: FDA rejection is a reality check on agency rhetoric By Meghana Keshavan STAT Plus: FDA is ‘not convinced’ UniQure’s Huntington’s therapy has benefit, senior official says By Adam Feuerstein STAT Plus: FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad By Lizzy Lawrence and John Wilkerson STAT Plus: A rare disease drug was approvable, then it wasn’t.

Why This Matters

Inside a surprise rejection By Adam Feuerstein STAT Plus: Jeffrey Epstein’s tissue samples ignited a furor in the Harvard lab of George Church By Megan Molteni STAT Plus: Brain implants: Whats standing in the way of pivotal trials, FDA approval By O.

Medical professionals are taking note of this development.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

Thoughts? Drop them below.